March 2016

6 March 2016

Wanted Regulatory Affairs Manager in SA Technologies

SA Technologies is one of the leading premier IT Consulting Companies in Santa Clara. SAT is an Oracle Gold Partner & Microsoft Partner. We have built highly scalable, world-class consulting processes that offer tremendous business advantages to our clients in the form of huge cost-benefits, definitive results and consistent project deliveries.

Post: Regulatory Affairs Manager

6 March 2016

Job as Bioanalytical Scientist in reputed Pharma company - Client of Nurture Consultancy

We are hiring for reputed Pharma consulting company in Mahape, Navi Mumbai

Post: Bioanalytical Scientist

6 March 2016

Application are invited for Novus Biologicals Scholarship Program - 2016

The Novus Biologicals Scholarship Fund was established to recognize students looking to advance their knowledge and career in science. Research is a critical component for the development and advancement in the life science community. We want to further scientific achievement by helping students who are interested in developing a career in science.

6 March 2016

4th International Conference on Theranostic Nanoparticles at Shree Dhanvantary Pharmacy College

5 March 2016

Drug Inspector Question Paper 2015

DRUG INSPECTOR
COMPUTER BASED RECRUITMENT TEST HELD IN THE YEAR 2015

1. Zero order kinetics is seen in all except:
(a) Salicylates
(b) Barbiturates
(c) Phenytoin
(d) Ethanol

5 March 2016

Opportunity to work as DRUG INSPECTOR (5 posts) under Food & Drug Administration

MPSC invites applications by online method for post of Drug Inspector under Food & Drug Administration, Medical Education and Research Services. For these vacant positions, candidates can apply by following below rules.

Post: Drug Inspectors

Read more about Novel compound protects monkeys from Ebola virus

In an advance towards an effective treatment against the deadly Ebola virus disease, researchers have found that an antiviral compound that blocks the virus's ability to replicate can fully protect monkeys when treated three days after infection.

Read more about AstraZeneca enters into agreement with ProStrakan for rights to Moventig in Europe

AstraZeneca announced that it has entered into an agreement with ProStrakan Group, a subsidiary of Kyowa Hakko Kirin Co. Ltd., for the rights to Moventig (naloxegol) in the European Union (EU), Iceland, Norway, Switzerland and Liechtenstein. Moventig is the first once-daily, oral peripherally-acting mu-opioid receptor antagonist (PAMORA) approved in Europe for the treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response to laxative(s).

Read more about BioMarin receives Orphan Drug Designation from FDA for BMN 270

BioMarin Pharmaceutical Inc. Announced that BMN 270, an investigational gene therapy for the treatment of patients with hemophilia A, has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA). BioMarin is currently conducting a Phase 1/2 study to evaluate the safety and efficacy of BMN 270 gene therapy in up to 12 patients with severe hemophilia A and will provide a program update in April. BMN 270 is an AAV 5 factor VIII vector, designed to restore factor VIII plasma concentrations, essential for blood clotting in patients with hemophilia A.

Read more about Edwards SAPIEN XT Valve receives FDA approval for Pulmonic Procedures

Edwards Lifesciences Corporation announced U.S. Food and Drug Administration approval to expand use of the Edwards SAPIEN XT transcatheter heart valve for pulmonic valve replacement procedures.